Phase 4 Alopecia Areata Trial, Recruiting (NCT04207931)

Phase 4 Alopecia Areata Trial, Recruiting NCT04207931 Sponsor: Wake Forest University Health Sciences Condition: Alopecia Areata

Printed from Voxsanity (voxsanity.com.au) — NCT04207931 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Alopecia Areata

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are an African-American woman between 18 and 60 years old
You have been diagnosed with a specific type of hair loss called CCCA (Central Centrifugal Cicatricial Alopecia), confirmed by a skin biopsy, with a severity level between 1 and 4 on a standard scale
You are able to be seen and treated at the Wake Forest Baptist Health Dermatology Outpatient Clinic

Who may not be able to join:

You have other types of hair loss in addition to CCCA
You have other inflammatory scalp conditions (having mild dandruff-related scalp condition may still be acceptable — confirm with trial site)
You have used any creams, lotions, or other products applied directly to the scalp for CCCA in the past 4 months (such as steroid creams, minoxidil, or other hair regrowth products)
You have taken long-term antibiotic tablets or capsules for hair loss within the past year
You have had more than two sessions of steroid injections directly into the scalp in the past year

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Amy J McMichael, MD, Wake Forest Baptist Health Department of Dermatology

Phone: 336.716.3926

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04207931

Sponsor: Wake Forest University Health Sciences

Phase: Phase 4

Status: Recruiting

Condition: Alopecia Areata

Trial contact: 336.716.3926

More information: https://clinicaltrials.gov/study/NCT04207931

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are an African-American woman between 18 and 60 years old
You have been diagnosed with a specific type of hair loss called CCCA (Central Centrifugal Cicatricial Alopecia), confirmed by a skin biopsy, with a severity level between 1 and 4 on a standard scale
You are able to be seen and treated at the Wake Forest Baptist Health Dermatology Outpatient Clinic

Who may not be able to join:

You have other types of hair loss in addition to CCCA
You have other inflammatory scalp conditions (having mild dandruff-related scalp condition may still be acceptable — confirm with trial site)
You have used any creams, lotions, or other products applied directly to the scalp for CCCA in the past 4 months (such as steroid creams, minoxidil, or other hair regrowth products)
You have taken long-term antibiotic tablets or capsules for hair loss within the past year
You have had more than two sessions of steroid injections directly into the scalp in the past year

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

Wake Forest University Health Sciences

Registry

ClinicalTrials.gov

Start date

30 April 2018

Est. completion

1 November 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Central Scalp Alopecia Photographic Scale in African American Women; Central Scalp Alopecia Photographic Scale in African American Women

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov